Compounds > itraconazole

itraconazole and Pancreatic Neoplasms

itraconazole has been researched along with Pancreatic Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, K; Cheng, L; Duan, W; Jiang, Z; Ma, Q; Qian, W; Sun, L; Wang, P; Yang, W; Zhao, L; Zhao, Y; Zhou, Y	1
Chen, WY; Du, J; Jiang, F; Lin, AY; Ruan, YL; Xing, HS; Zhou, CZ	1
Lockhart, NR; Schrock, NE; Waddell, JA	1
Ikuta, S; Inoue, K; Sonoda, T; Tani, S; Tsubamoto, H; Yamanaka, N	1

Other Studies

4 other study(ies) available for itraconazole and Pancreatic Neoplasms

Article	Year
Itraconazole inhibits invasion and migration of pancreatic cancer cells by suppressing TGF-β/SMAD2/3 signaling. Oncology reports, 2018, Volume: 39, Issue:4 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Humans; Itraconazole; Mice; Mice, Transgenic; Neoplasm Invasiveness; Pancreatic Neoplasms; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta	2018
Itraconazole inhibits proliferation of pancreatic cancer cells through activation of Bak-1. Journal of cellular biochemistry, 2019, Volume: 120, Issue:3 Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Itraconazole; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred ICR; Pancreatic Neoplasms; Reactive Oxygen Species; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays	2019
Itraconazole therapy in a pancreatic adenocarcinoma patient: A case report. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2016, Volume: 22, Issue:3 Topics: Adenocarcinoma; Antifungal Agents; Antineoplastic Agents; Humans; Itraconazole; Male; Middle Aged; Pancreatic Neoplasms	2016
Combination Chemotherapy with Itraconazole for Treating Metastatic Pancreatic Cancer in the Second-line or Additional Setting. Anticancer research, 2015, Volume: 35, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Itraconazole; Male; Middle Aged; Pancreatic Neoplasms; Retrospective Studies; Taxoids	2015